Risk of cardiovascular events and rofecoxib: cumulative meta-analysis.
Lancet. 2004 Dec 4-10;364(9450):2021-9. doi: 10.1016/S0140-6736(04)17514-4.
Lancet. 2004.
PMID: 15582059